T 2898/18 (Antibody binding to alpha-synuclein/PROTHENA) of 04.05.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T289818.20210504
- Date of decision
- 4 May 2021
- Case number
- T 2898/18
- Petition for review of
- -
- Application number
- 06800177.5
- IPC class
- C07K 16/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prevention and treatment of synucleinopathic and amyloidogenic disease
- Applicant name
- Prothena Biosciences Limited
The Regents of the University of California - Opponent name
- MacLean, Martin Robert
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention R 31Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendments - added subject-matter (yes)
Amendment after summons - taken into account (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.